Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 295
1 241 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$999.84 |
-1.4%
|
$945.2B |
|
|
|
Johnson & Johnson
JNJ
|
$242.99 |
+0.6%
|
$585.4B |
|
|
|
Roche Holding AG
ROG
|
CHf330.2 |
-0.4%
|
$345.4B |
|
|
|
Novartis AG
NOVN
|
CHf121.8 |
+0.1%
|
$302.1B |
|
|
|
AstraZeneca PLC
AZN
|
GBX14 360 |
-0.1%
|
$300.5B |
|
|
|
Merck & Co Inc
MRK
|
$116.21 |
+0.3%
|
$288.4B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr250 |
-1.9%
|
$175.1B |
|
|
|
Pfizer Inc
PFE
|
$27.3 |
+0.4%
|
$155.2B |
|
|
|
Bristol-Myers Squibb Co
BMY
|
$59.98 |
+0.6%
|
$122.1B |
1 236 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
